Delivery Order SPE2DB22D3009-SPE2DB25FBA05
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 units of 30 mg Lisdexamfetamine capsules. The contract has a completion date of July 17, 2025, and a ceiling value of $1,697.92. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor for this contract, which supports medical procurement...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, which is not set aside, is for the delivery of Lisdexamfetamine 70 mg capsules in 100-count bottles. The contract has a ceiling value of $5,023.90 and a period of performance ending on June 25, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of lisdexamfetamine 30 mg capsules in 100-count packages, with a total ceiling value of $2,948.09 and a period of performance through May 28, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp is the prime...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the provision of Lisdexamfetamine 10 mg capsules. The contract has a ceiling value of $2,968.45 and a completion date of June 12, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Lisdexamfetamine 20 mg capsules. The $1,029.60 contract has a completion date of July 3, 2025 and is not a set-aside award. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00, which allows the company to supply a wide range of pharmaceutical...
- This is a $1,254.83 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 100 units of the medication lisdexamfetamine 30 mg capsules. The contract has a performance period ending on June 12, 2025 and does not utilize a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of lisdexamfetamine 50 mg capsules, a prescription medication, with a ceiling value of $1,674.91 and a period of performance through April 7, 2025. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Lisdexamfetamine 50 mg capsules in 100-count quantities, with a ceiling value of $1,070.26 and a completion date of July 7, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Lisdexamfetamine 60 mg capsules in 100-count packages. The contract has a firm fixed price of $7,408.93 and a completion date of June 11, 2025. This contract award is not designated as a set-aside contract. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,355.37 firm fixed-price delivery order is for the supply of 100 capsules of the prescription medication Lisdexamfetamine 60 mg. The contract has an ultimate completion date of May 12, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- SPE2DB22D3009Indefinite Delivery Contract
- SPE2DB22D3009-SPE2DB25FBA05Delivery Order
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of lisdexamfetamine 70 mg capsules in 100-count packages, with a ceiling value of $2,157.67 and a performance period ending on June 27, 2025. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor, and the contract is part of the company's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.2k | 6/26/25 |